OphthaFund (@ophthafund) 's Twitter Profile
OphthaFund

@ophthafund

We are early stage investors focused on the future of ophthalmology & life sciences.

ID: 1756072740186914816

linkhttps://www.ophthafund.com calendar_today09-02-2024 21:51:09

5 Tweet

13 Followers

1 Following

OphthaFund (@ophthafund) 's Twitter Profile Photo

OphthaFund works to connect investors with innovative ideas to achieve their long-term Ophthalmology success. OphthaFund’s directors provide extensive research into intellectual property, company guidance, and proposed markets for start-ups and emerging technologies.

OphthaFund works to connect investors with innovative ideas to achieve their long-term Ophthalmology success. OphthaFund’s directors provide extensive research into intellectual property, company guidance, and proposed markets for start-ups and emerging technologies.
OphthaFund (@ophthafund) 's Twitter Profile Photo

OphthaFund co-founder and board-certified ophthalmologist Tom Mather brings 35 years of industry experience to the firm. Dr. Mather has assisted numerous start-up companies in developing eye care advancements and currently serves on the board for MCAL Therapeutics. #ophthalmology

OphthaFund co-founder and board-certified ophthalmologist Tom Mather brings 35 years of industry experience to the firm. Dr. Mather has assisted numerous start-up companies in developing eye care advancements and currently serves on the board for MCAL Therapeutics. #ophthalmology
OphthaFund (@ophthafund) 's Twitter Profile Photo

Andrea H. Marshall, J.D. is an accomplished legal professional with a background spanning executive roles in emerging technologies, including biopharmaceuticals, and expertise in corporate law. Andrea drives innovation and commercialization at OphthaFund. #Executive #Innovation

Andrea H. Marshall, J.D. is an accomplished legal professional with a background spanning executive roles in emerging technologies, including biopharmaceuticals, and expertise in corporate law. Andrea drives innovation and commercialization at OphthaFund. #Executive #Innovation